Q: Do you know if the Mawer New Canada Fund sold a significant part or all of its position in CRH ? If so, when did they do it ? Also when will the decision on the new reimbursement rates be final ?
You can view 3 more answers this month. Sign up for a free trial for unlimited access.
Investment Q&A
Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.
Q: TD Waterhouse Action Notes Summary Report dated July 7 2017 about "Questions regarding the sustainability of CRH's reimbursement rates have contributed to a two month slide in CRH's stock."
Here's the meat of it.
" We expect a relatively benign outcome to the 2018 fee schedule, partly because of CRH's limited exposure to CMS funding. Our sensitivity analysis indicates that a 5% cut in the Medicare reimbursement fee could cost CRH ~1% in adjusted EBITDA. ....
CRH has limited exposure to MEDICARE- We expect CRH's operating performance to be largely insulated from CMS for two reasons. First, Medicare only represents 10 to 15 % of CRH's revenues. Second, CRH's dominant payers (the private insurers) employ different reimbursement protocols from Medicare. We estimate that commercial payers reimburse the 00810 code at 3X-4X the rate of government payers.
TD Investment Conclusion
We are maintaining our buy rating but reducing our target price to $10.50 (was $12).
Our rating is based on three considerations: 1) leadership in a defensive, growing segment of the U.S. healthcare services market: 2) high margin cash flow streams and: 3) expansion opportunities within CRH's core anesthesiology market.
Hope this soothes a bit!
Here's the meat of it.
" We expect a relatively benign outcome to the 2018 fee schedule, partly because of CRH's limited exposure to CMS funding. Our sensitivity analysis indicates that a 5% cut in the Medicare reimbursement fee could cost CRH ~1% in adjusted EBITDA. ....
CRH has limited exposure to MEDICARE- We expect CRH's operating performance to be largely insulated from CMS for two reasons. First, Medicare only represents 10 to 15 % of CRH's revenues. Second, CRH's dominant payers (the private insurers) employ different reimbursement protocols from Medicare. We estimate that commercial payers reimburse the 00810 code at 3X-4X the rate of government payers.
TD Investment Conclusion
We are maintaining our buy rating but reducing our target price to $10.50 (was $12).
Our rating is based on three considerations: 1) leadership in a defensive, growing segment of the U.S. healthcare services market: 2) high margin cash flow streams and: 3) expansion opportunities within CRH's core anesthesiology market.
Hope this soothes a bit!
Q: Some news out on WSP Global I haven't heard? Stock is down heavily on an up day.
Q: Please comment on the release of 2018 CMS reimbursement rate and its impact on CRH going forward.
FJ
FJ
Q: I am recently out of university and have gotten a full time job with a defined benefits pension plan. I have 25-30 years before I am going to retire and want to start developing my first portfolio. I have lots of room in my TFSA and RRSP. I have a moderate risk tolerance given the pension plan.
I currently have $50K to invest. I would like to build a portfolio with a mix of some of your balanced and growth model portfolio stocks.
A few questions for you:
1) How many stocks would you recommend be a good starting point for me? Or would you suggest that ETFs would be a better approach for me given the amount of money I have to invest initially? From reading the forums I get a sense that I need to ensure a certain amount of portfolio diversity.
2) If I were to invest today, what stocks would you recommend from your BE and growth portfolio for the long term (20+ years in my situation).
Feel free to dock as many credits as you feel appropriate.
Thanks so much for your service. I have learned a lot since becoming a member and look forward to being a member for a very long time.
I currently have $50K to invest. I would like to build a portfolio with a mix of some of your balanced and growth model portfolio stocks.
A few questions for you:
1) How many stocks would you recommend be a good starting point for me? Or would you suggest that ETFs would be a better approach for me given the amount of money I have to invest initially? From reading the forums I get a sense that I need to ensure a certain amount of portfolio diversity.
2) If I were to invest today, what stocks would you recommend from your BE and growth portfolio for the long term (20+ years in my situation).
Feel free to dock as many credits as you feel appropriate.
Thanks so much for your service. I have learned a lot since becoming a member and look forward to being a member for a very long time.
Q: Any news/reason for BCE to decline from $63.40 high @ end of April.Is this a entry point, or you have other preference Thanks for u usual great views & services,
Q: As a recent subscriber and investor, I note that several stocks that I own have the option of DRIP. My portfolio is large enough that the quarterly dividends allow for a substantial purchase of new or existing additions to stocks, like CAE or Boyd. As the cost of buying the stocks is not overly impactful to the purchase, is foregoing the drip, and the 5% discount, advisable, in order to allow a choice in selecting stock picks?
Thanks. KC
Thanks. KC
-
Savaria Corporation (SIS $21.66)
-
goeasy Ltd. (GSY $132.07)
-
ZCL Composites Inc. (ZCL $10.00)
-
Spin Master Corp. Subordinate Voting Shares (TOY $20.47)
Q: Hi team
I have a half position on the above except for ZCL which I sold it earlier for a small gain, which one of the above would you add on to the postion from my cash ? Thanks
Michael
I have a half position on the above except for ZCL which I sold it earlier for a small gain, which one of the above would you add on to the postion from my cash ? Thanks
Michael
Q: KWH down 1.39% @ $9.91 today.I think recent financing was$9.80.Reporting on 8/14.Is this a good entry point.Appreciate u usual great views & services
Q: Hi Peter
I am thinking of taking a half position on this stock you ok at these levels?
Kind Regards
Stan
I am thinking of taking a half position on this stock you ok at these levels?
Kind Regards
Stan
Q: Where can I find past model portfolio updates? I am a new member and would like to review the historical trades in the portfolios along with a brief description but I can't find anywhere that has past trades unless I open up every monthly report.
Q: Hi, with the rise in interest rates, I was expecting to see a bit more of a bounce in SLF and MFC. Currently, I have a 1% position at a much lower entry price on SLF, and about a 4.5% position in MFC. Would adding more SLF here for a longer term hold now that rates have moved up here make sense? The entire portfolio is pretty well diversified and I have time on my side.
Q: Do you still recommend holding onto this position? I have watched it fall by about 50% and it looks like it wants to drop further.
Q: I have purchased 2500 shares of PLI over the year at varying prices from 2.40 to 1.60. At 1.50 today would this be a good opportunity to average down and buy more. Your opinion is much appreciated.
Q: Please comment on earnings.
Thx
Thx
Q: There has been a fair bit of insider trading in ET since its last earnings report. Do you know how much insiders own of this company? I wonder if this suggests the next earning won't surprise to the upside like the last earnings did?
Q: CIBC has issued a downgrade on PLI reducing their target price from $4.40 to $2.15. I don not usually pay any attention to target prices but this seems to be a significant cut. They also mention cash burn rate and that the company will likely need additional financing.
Would appreciate your views on this. Thanks John
Would appreciate your views on this. Thanks John
Q: I am interested in PUR but the stock seems incredibly expensive on a P/E
basis for a company which has disappointed with flat earnings for a while.
Even their dividend is not covered by earnings. Can you explain why you like it so much?
Thanks
basis for a company which has disappointed with flat earnings for a while.
Even their dividend is not covered by earnings. Can you explain why you like it so much?
Thanks
Q: I am retired and able to live comfortably on
my Federal government superannuation, OAS and CPP.
Can you recommend a single stock for a TFSA, in which I currently hold a full position in ENF and a double position in AYA purchased when originally recommended by 5i?
Thank you for considering my question.
my Federal government superannuation, OAS and CPP.
Can you recommend a single stock for a TFSA, in which I currently hold a full position in ENF and a double position in AYA purchased when originally recommended by 5i?
Thank you for considering my question.
Q: Hello team,
Please advise what is in vogue regarding dividends accumulated in both registered and non registered accounts. I am able to reinvest these as it is not an issue in the non registered account, which has the bulk of the dividends. Would you recommend reinvesting in growth stocks,IE growth portfolio, or to plow back into the Beport stocks?
the dividends amount to roughly a 1/2 position in my current holdings.
Thanks
KC
Please advise what is in vogue regarding dividends accumulated in both registered and non registered accounts. I am able to reinvest these as it is not an issue in the non registered account, which has the bulk of the dividends. Would you recommend reinvesting in growth stocks,IE growth portfolio, or to plow back into the Beport stocks?
the dividends amount to roughly a 1/2 position in my current holdings.
Thanks
KC